No abstract available
MeSH terms
-
Aged
-
Antineoplastic Agents / administration & dosage*
-
Autopsy
-
Benzamides
-
Drug Resistance, Neoplasm
-
Fatal Outcome
-
Gene Fusion
-
Humans
-
Hypereosinophilic Syndrome / complications
-
Hypereosinophilic Syndrome / drug therapy
-
Hypereosinophilic Syndrome / genetics
-
Hypereosinophilic Syndrome / pathology*
-
Imatinib Mesylate
-
Male
-
Piperazines / administration & dosage*
-
Pneumothorax / etiology*
-
Pneumothorax / pathology*
-
Pyrimidines / administration & dosage*
-
Receptor, Platelet-Derived Growth Factor alpha / genetics
-
mRNA Cleavage and Polyadenylation Factors / genetics
Substances
-
Antineoplastic Agents
-
Benzamides
-
FIP1L1 protein, human
-
Piperazines
-
Pyrimidines
-
mRNA Cleavage and Polyadenylation Factors
-
Imatinib Mesylate
-
Receptor, Platelet-Derived Growth Factor alpha